Results

Total Results: 2,184 records

Showing results for "harms".

  1. S96 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/s96.pdf
    October 01, 2007 - ORIGINAL ARTICLE Evaluation and Overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES) Michael A. Jhung, MD, MPH,* Daniel S. Budnitz, MD, MPH,* Aaron B. Mendelsohn, PhD,*† Kelly N. Weidenbach, MPH,* Theresa D. Nelson, MS,‡ and Daniel A. Polloc…
  2. effectivehealthcare-admin.ahrq.gov/products/cancer-end-of-life-indicators-symposium/research
    January 01, 2020 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/crohns-disease_executive.pdf
    February 01, 2014 - These areas include treatments to achieve long-term remission, the benefits and harms of step-up versus
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/research-gaps_research.pdf
    February 01, 2013 - Methods Research Report - Framework for Determining Research Gaps During Systematic Review: Evaluation Methods Research Report Framework for Determining Research Gaps During Systematic Review: Evaluation Methods Research Report Framework for Determining Research Gaps During …
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
    August 01, 2012 - CER # 23: Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis Original release date: October 2010 Surveillance Report 1st Assessment: November, 2011 Surveillance Report 2nd Assessment: August 2012 Key Findings 1st Assessment: • All conclusions for KQ…
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-function_executive.pdf
    August 01, 2014 - diabetes, hypertension), smoking status, 10-year CAD predicted risk, or history of CAD 1.3 What are the harms … No study addressed harms associated with a false positive diagnosis. 11 Ta b le D .
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
    March 19, 2018 - KQ addressed in this review were determined during the protocol and did not include specific drug harms
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_research-protocol.pdf
    February 04, 2014 - observational study evidence may also be initially graded as “moderate” for certain outcomes such as important harms
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/autism-adolescents_disposition-comments.pdf
    August 27, 2012 - Need to highlight main point and to use language less tied to the jargon of this specific field (e.g. harms
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/obesity-child_executive.pdf
    March 31, 2010 - None of these studies reported on adverse events (harms).
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/Masks-appendix-table-b-1-surveillance-report.xlsx
    April 09, 2020 - Coronavirus Infection – Results Work-Related Outcomes – Definition Work-Related Outcomes – Results Harms
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-1-version-1.xlsx
    April 09, 2020 - Coronavirus Infection – Results Work-Related Outcomes – Definition Work-Related Outcomes – Results Harms
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-1.xlsx
    April 09, 2020 - Coronavirus Infection – Results Work-Related Outcomes – Definition Work-Related Outcomes – Results Harms
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/masks-appendix-table-b-1-version-2.xlsx
    April 09, 2020 - Coronavirus Infection – Results Work-Related Outcomes – Definition Work-Related Outcomes – Results Harms
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/musculoskeletal-disorders-imaging_disposition-comments.pdf
    November 01, 2011 - . b) Little information is presented in previous sections to support the statement that potential harms
  16. 04-E029-1 Summary (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
    December 01, 2011 - Immediate active treatment has tradeoffs, including the harms of short- and long-term complications from
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/implementation-package-unhealthy-alcohol-use-final.pdf
    September 01, 2018 - system’s patient population is substantial, (2) the evidence base clearly shows that benefits outweigh harms
  18. effectivehealthcare-admin.ahrq.gov/products/allergy-seasonal/research-protocol
    December 01, 2020 - Potential comparative harms of intranasal corticosteroids in this population (reduced bone growth and
  19. effectivehealthcare-admin.ahrq.gov/products/head-neck-cancer-update/research-protocol
    December 01, 2019 - observational study evidence may also be initially graded as “moderate” for certain outcomes such as important harms
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
    December 31, 2013 - AHRQ Comparative Effectiveness Review Surveillance Program CER #27: Oral Diabetes Medications for Adults with Type 2 Diabetes: An Update Original release date: March 2011 Surveillance Report: December 2013 Key Findings: • For Key Question 1, conclusions on comparative effectiveness of oral diabetes agent…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: